What's breaking now, across thousands of outlets.
(RTTNews) - Biopharmaceutical company Verastem Oncology (VSTM), announced on Wednesday that it has priced an underwritten offering of 30.94 million shares at $8 each and pre-funded warrants for 0.31 million shares at $7.9999 each, raising about $250 million.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
India’s securities watchdog proposed sweeping changes to rules governing the listing and trading of small companies, seeking to ease access to capital markets and broaden investor participation.
The government initially declared 265 talukas drought-affected last month, citing a rainfall deficit, and announced several relief measures, including restructuring crop loans, waiving land revenue…
Key PointsThe last time the Fed began a rate-hike cycle, in 2022, cryptocurrency entered a bear market.
Ahead of AEW WrestleDream, Kyle Fletcher discusses his career growth since his first world title match, advice he received from Mark Davis, and The Young Bucks.
Not long ago, buying a car in Qatar meant a familiar routine. You’d spend a Friday bouncing between showrooms, take a couple of shaky test drives, then “check one more place” because your cousin’s…
